The best candidate for selective suppression of the tumor-specific PKC-α isoform turned out to be the thiophosphate asON ISIS 3521 (AffinitakTM, USA), which selectively binds the PKC-α mRNA and does not interact with the other, non-oncogenic members of the PKC family [55]. The gene discussed is PRKCA; the disease is neoplasm.